Paul V Maier's Net Worth

$93 Thousand

Estimate Recalculated Nov 1, 2024 05:49AM EST

Who is Paul V Maier?

Paul V Maier does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include International Stem Cell CORP, RITTER PHARMACEUTICALS INC, Eton Pharmaceuticals, Inc., PURE BIOSCIENCE, APRICUS BIOSCIENCES, INC., MABVAX THERAPEUTICS HOLDINGS, INC., Ambrx Biopharma Inc., SEQUENOM INC, Hana Biosciences Inc, and Ambrx Biopharma, Inc..

SEC CIK

Paul V Maier's CIK is 0001182615

Past Insider Trading and Trends

2016 was Paul V Maier's most active year for acquiring shares with 13 total transactions. Paul V Maier's most active month to acquire stocks was the month of May. 2013 was Paul V Maier's most active year for disposing of shares, totalling 8 transactions. Paul V Maier's most active month to dispose stocks was the month of June. 2017 saw Paul V Maier paying a total of $135,258.00 for 254,969 shares, this is the most they've acquired in one year. In 2018 Paul V Maier cashed out on 136,474 shares for a total of $30,299.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

International Stem Cell CORP (ISCO) Snapshot price: $0.068

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4/A
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 3
Form 4
-4.08%
-1.35K
$1.25
-$1,680.75
31.71K
Apr 18
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 31
Form 4
+16.33%
4.64K
—
—
33.06K
Mar 31
Form 4
+36.00%
7.52K
—
—
28.42K
Dec 30
Form 4
+6.82%
1.33K
—
—
20.89K
Oct 13
Form 4
+28.95%
4.39K
—
—
19.56K
Sep 30
Form 4
+36.32%
4.04K
—
—
15.17K
Jun 30
Form 4
—
0
—
—
0
May 17
Form 4
+23.32%
2.1K
—
—
11.13K
Mar 31
Form 4
+36.29%
2.4K
—
—
9.02K
Dec 31
Form 4
+43.62%
2.01K
—
—
6.62K
Sep 30
Form 4
+35.66%
181.77K
—
—
691.45K
Jun 30
Form 4
+24.39%
99.95K
—
—
509.68K
Apr 8
Form 4
+23.13%
76.96K
—
—
409.74K
Apr 3
Form 4
+17.54%
49.65K
—
—
332.78K
Oct 2
Form 4
+16.45%
40K
—
—
283.13K
May 8
Form 4
+201.55%
162.5K
—
—
243.13K
Mar 21
Form 4
+19.75%
40K
—
—
242.5K
Jun 20
Form 4
+406.25%
162.5K
—
—
202.5K
Jan 25
Form 4
∞
40K
—
—
40K
May 29
Form 4
—
0
—
—
0
May 3
Form 4
-19.23%
-10.00K
$1.36
-$13,605.00
42K
Scheduled
Mar 28
Form 4
-27.78%
-20.00K
$1.40
-$27,959.00
52K
Scheduled
Mar 24 - Mar 25
Form 4
-12.20%
-10.00K
$1.27
-$12,700.00
72K
Scheduled
Mar 21
Form 4
-19.61%
-20.00K
$1.42
-$28,410.00
82K
Scheduled
Feb 23 - Feb 24
Form 4
-16.39%
-20.00K
$1.55
-$31,002.00
102K
Scheduled
Feb 18 - Feb 22
Form 4/A
-24.69%
-40.00K
$1.84
-$73,748.00
122K
Scheduled
Jan 18 - Jan 21
Form 4
-24.69%
-40.00K
$1.84
-$73,748.00
122K
Scheduled
Jan 18 - Jan 21
Form 4
—
0
—
—
0
Jan 13
Form 4
-10.99%
-20.00K
$2.16
-$43,201.00
162K
Scheduled
Dec 20 - Dec 21
Form 4
-9.90%
-20.00K
$1.90
-$37,900.00
182K
Scheduled
Dec 16 - Dec 17
Form 4
-9.01%
-20.00K
$1.65
-$32,905.00
202K
Scheduled
Nov 17 - Nov 18
Form 4
-8.26%
-20.00K
$1.42
-$28,413.00
222K
Scheduled
Nov 15 - Nov 16
Form 4
-3.97%
-10.00K
$1.44
-$14,400.00
242K
Scheduled
Oct 20
Form 4
-10.64%
-30.00K
$1.31
-$39,338.00
252K
Scheduled
Oct 15 - Oct 19
Form 4
—
0
—
—
0
Dec 10
Form 4
+14,000.00%
280K
—
—
282K
Dec 29
Form 4
—
0
—
—
0
Apr 22
Form 4
∞
2K
$1.70
$3,400.00
2K
Jul 20
Form 3
—
0
—
—
0
No matching records found

RITTER PHARMACEUTICALS INC (QLGN) Snapshot price: $0.154

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Nov 29
Form 4
—
0
—
—
0
Oct 13
Form 3
—
0
—
—
0
No matching records found

Eton Pharmaceuticals, Inc. (ETON) Snapshot price: $4.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Feb 20
Form 4
+9.13%
5K
$6.00
$30,000.00
59.74K
Nov 15
Form 3
—
0
—
—
0
No matching records found

PURE BIOSCIENCE (PURE) Snapshot price: $0.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.75%
13.71K
$0.38
$5,209.80
69.11K
Jul 31
Form 4/A
+31.59%
13.3K
$2.13
$28,329.00
55.4K
Jan 21
Form 4
+30.16%
13.3K
$2.13
$28,329.00
57.4K
Jan 21
Form 4
+94.01%
20.4K
$3.03
$61,812.00
42.1K
May 6
Form 4
∞
21.7K
$2.34
$50,778.00
21.7K
May 14
Form 4
—
0
—
—
0
Apr 9
Form 3
—
0
—
—
0
No matching records found

APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.2305

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
+432.03%
11.25K
—
—
13.85K
Jan 5
Form 4
+69.92%
10.71K
$0.34
$3,624.88
26.04K
Sep 30
Form 4
+145.18%
9.07K
$0.40
$3,625.06
15.32K
Jun 30
Form 4
∞
6.25K
$0.58
$3,625.00
6.25K
Apr 5
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found